Outcome of infants exposed to olanzapine during breastfeeding.
Gilad
Oded
O
Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
Merlob
Paul
P
Stahl
Bracha
B
Klinger
Gil
G
D000328:Adult; D014150:Antipsychotic Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D001569:Benzodiazepines / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D001942:Breast Feeding / Q000009:adverse effects*; D002675:Child, Preschool; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007229:Infant Welfare; D007774:Lactation / Q000378:metabolism*; D018811:Maternal Exposure / Q000009:adverse effects*; D008431:Maternal-Fetal Exchange; D008895:Milk, Human / Q000737:chemistry / Q000378:metabolism; D000077152:Olanzapine; D011247:Pregnancy; D011256:Pregnancy Outcome; D011446:Prospective Studies
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine